LAST April’s swine flu outbreak in the United States and Mexico brought a “blessing” for Indonesia. In early November 2009, Airlangga University’s Influenza Tropical Disease Center managed to formulize a vaccine from local specimens. It is currently being mass-produced, and will be available for public consumption by 2010, at an affordable price, of course.

The H1N1 sub-type of the Influenza A virus, which causes this particular influenz